TwinBeech Capital’s Pediatrix Medical MD Stock Holding History

TwinBeech Capital’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-46,349	Closed	-$1.32M	–	712
2021 Q3	$1.32M	Buy	46,349 +27,757	+149%	+$846K	0.09%	282
2021 Q2	$561K	Buy	+18,592	New	+$549K	0.07%	290
2020 Q4	–	Sell	-17,513	Closed	-$285K	–	545
2020 Q3	$285K	Buy	+17,513	New	+$326K	0.06%	349

Other funds holding MD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Starboard Value New York $4.57B AUM 4.97% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

TwinBeech Capital's MD Position: Q4 2021 in Review

TwinBeech Capital sold out of Pediatrix Medical (MD) in Q4 2021, closing a stake of 46,349 shares — an estimated $1.32M sold.

TwinBeech Capital first reported a position in MD in Q3 2020 and held it in 3 quarters. The position peaked at $1.32M in Q3 2021. 204 funds tracked by Wall St. Rank hold MD as of Q4 2021.

TwinBeech Capital reported no remaining Pediatrix Medical position as of Q4 2021 after selling out during the quarter.
TwinBeech Capital sold 46,349 Pediatrix Medical shares in Q4 2021, an estimated $1.32M.
TwinBeech Capital first reported a position in Pediatrix Medical in Q3 2020 and held it in 3 quarters.
TwinBeech Capital's Pediatrix Medical position peaked at $1.32M in Q3 2021.
204 funds tracked by Wall St. Rank held Pediatrix Medical as of Q4 2021.

Based on TwinBeech Capital's 13F filing for Q4 2021, filed 14 Feb 2022.